Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis
| Autor: | Shroff, R., Wan, M., Nagler, E. V., Bakkaloglu, S., Cozzolino, M., Bacchetta, J., Edefonti, A., Stefanidis, C. J., Vande Walle, J., Ariceta, G., Klaus, G., Haffner, D., Schmitt, C. P., Prytula, A., Reusz, G., Verrina, E., Groothoff, J., Gamero, M. A., Petrosyan, E., Dursun, I., Aufricht, C., Vondrak, K., Holtta, T., Ranchin, B., Fischbach, M., Printza, N., Vidal, E., Jankauskiene, A., Zurowska, A., Do Sameiro Faria, M., Sartz, L., Karabay Bayazit, A., Duzova, A., Hothi, D. |
|---|---|
| Přispěvatelé: | Çukurova Üniversitesi |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Paricalcitol
Pediatrics medicine.medical_specialty medicine.medical_treatment 030232 urology & nephrology Chronic kidney disease (CKD) 030204 cardiovascular system & hematology urologic and male genital diseases CKD-MBD Dialysis Vitamin D Child Chronic Kidney Disease-Mineral and Bone Disorder Humans Meta-Analysis as Topic Observational Studies as Topic Practice Guidelines as Topic Prospective Studies Randomized Controlled Trials as Topic Renal Insufficiency Chronic Vitamin D Deficiency Renal Dialysis law.invention Peritoneal dialysis 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Randomized controlled trial law medicine Vitamin D and neurology Hypocalcaemia Renal Insufficiency Chronic Transplantation business.industry Alfacalcidol medicine.disease female genital diseases and pregnancy complications chemistry Special Reports Nephrology Physical therapy Secondary hyperparathyroidism business medicine.drug Kidney disease |
| ISSN: | 2887-3971 |
| Popis: | PubMedID: 28873971 In patients with chronic kidney disease (CKD), renal synthesis of active Vitamin D [1, 25-dihydroxyVitamin D (1, 25(OH)2D)] declines and is associated with hypocalcaemia, secondary hyperparathyroidism and the spectrum of CKD-mineral and bone disorder (MBD). In advanced CKD, active Vitamin D analogues, including alfacalcidol, calcitriol and paricalcitol, are routinely administered. There are few studies on the use of Vitamin D analogues in children with CKD and on dialysis. It is difficult to define bone-specific outcomes that can guide treatment with active Vitamin D analogues in children with CKD-MBD. A core working group (WG) of the European Society for Paediatric Nephrology (ESPN) CKD-MBD and Dialysis WGs has developed recommendations for the use of active Vitamin D therapy in children with CKD and on dialysis. A second document in parallel with this one covers treatment recommendations for native Vitamin D therapy. The WGs have performed an extensive literature review to include systematic reviews and randomized controlled trials in adults and children with CKD and prospective observational studies in children with CKD. The Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system was used to develop and grade the recommendations. In the absence of applicable study data, the opinion of experts from the ESPN CKD-MBD and Dialysis WGs is provided, but clearly GRADE-ed as such and must be carefully considered by the treating physician and adapted to individual patient needs as appropriate. © The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. National Institute for Health Research RS holds a fellowship with the National Institute for Health Research (NIHR). Members of the ESPN CKD-MBD Working Group: Belgium: A. Prytula, Ghent University, Utopaed. France: J. Bachetta., University Children’s Hospital, Lyon. Germany: D. Haffner., Hannover Medical School, Hannover. G. Klaus, University Children’s Hospital, Marburg. Hungary: G. Reusz, Semmelweis University, Budapest. Italy: E. Verrina, G. Gaslini Institute, Genoa. The Netherlands: J. Groothoff, Academic Medical Center, Amsterdam. Spain: M.A. Gamero, Reina Sofía Universitary Hospital, Córdoba. Russia: E. Petrosyan, Russian National Research Medical University, Moscow. Turkey: S. A. Bakkaloglu, Gazi University Hospital, Ankara; I. Dursun, Erciyes University Faculty of Medicine, Kayseri. United Kingdom: R. Shroff, Great Ormond Street Hospital, London. Members of the ESPN Dialysis Working Group: Austria: C. Aufricht, Medical University of Vienna, Vienna. Belgium: J. Vande Walle, University Hospital Ghent, Department of Pediatric Nephrology/Urology, Ghent. Czech Republic: K. Vondrak, University Hospital Motol, Charles University Prague, 2nd Faculty of Medicine, Prague. Finland: T. Holtta, Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki. France: B. Ranchin, Centre de Référence des Maladies Rénales Héréditaires, Hospices Civils de Lyon and Université Lyon, Lyon. M. Fischbach, Hautepierre University Hospital, Strasbourg. Germany: Claus Peter Schmitt, University of Heidelberg, Heidelberg. Günter Klaus, University Children’s Hospital, Marburg. Greece: Constantinos J. Stefanidis, A. and P. Kyriakou Childrens Hospital, Athens; N. Printza, Aristotle University of Thessaloniki, Thessaloniki. Italy: Alberto Edefonti, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan; E. Verrina, Giannina Gaslini Children’s Hospital, Dialysis Unit, Genova; E. Vidal, University Hospital of Padova, Padova. Lithuania: A. Jankauskiene, Vilnius |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|